Login / Signup

Bevacizumab plus cisplatin/pemetrexed then bevacizumab alone for unresectable malignant pleural mesothelioma: A Japanese safety study.

Takashi NakanoKozo KuribayashiMasashi KondoMasahiro MoriseYuji TadaKatsuya HiranoMorihiko HayashiMisa TanakaMasataka Hirabayashi
Published in: Asia-Pacific journal of clinical oncology (2020)
Bevacizumab plus cisplatin/pemetrexed then bevacizumab was well tolerated in Japanese patients with MPM.
Keyphrases
  • metastatic colorectal cancer
  • small cell lung cancer
  • advanced non small cell lung cancer
  • radiation therapy